Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
RESEARCH TOOLSreports
Bolt Biotherapeutics (BOLT) Stock Price & Analysis
183 Followers
BOLT Stock Chart & Stats
Day’s Range$1.09 - $1.17
52-Week Range― - ―
Previous Close$1.11
Volume97.41K
Average Volume (3M)N/A
Market Cap
$44.21M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$6.50Price Target Upside460.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bolt Biotherapeutics News
Ownership Overview
43.52% Insiders
3.80% Mutual Funds
12.20% Other Institutional Investors
40.47% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BOLT FAQ
What was Bolt Biotherapeutics’s price range in the past 12 months?
Currently, no data Available
What is Bolt Biotherapeutics’s market cap?
Currently, no data Available
When is Bolt Biotherapeutics’s upcoming earnings report date?
Bolt Biotherapeutics’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were Bolt Biotherapeutics’s earnings last quarter?
Bolt Biotherapeutics released its earnings results on Mar 21, 2024. The company reported -$0.47 earnings per share for the quarter, the consensus estimate of -$0.47 by $0.
Is Bolt Biotherapeutics overvalued?
According to Wall Street analysts Bolt Biotherapeutics’s price is currently Undervalued.
Does Bolt Biotherapeutics pay dividends?
Bolt Biotherapeutics does not currently pay dividends.
What is Bolt Biotherapeutics’s EPS estimate?
Bolt Biotherapeutics’s EPS estimate is -$0.51.
How many shares outstanding does Bolt Biotherapeutics have?
Currently, no data Available
What happened to Bolt Biotherapeutics’s price movement after its last earnings report?
Bolt Biotherapeutics reported an EPS of -$0.47 in its last earnings report, expectations of -$0.47. Following the earnings report the stock price went up 3.448%.
Which hedge fund is a major shareholder of Bolt Biotherapeutics?
Among the largest hedge funds holding Bolt Biotherapeutics’s share is Hawkeye Capital Management, LLC. It holds Bolt Biotherapeutics’s shares valued at 465K.
---
Bolt Biotherapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.50 (460.59% Upside)
$6.50 (460.59% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.6%
Last 30 Days ▼ 6.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-27.45%
12-Months-Change
Fundamentals
Return on Equity
-48.69%
Trailing 12-Months
Asset Growth
-29.86%
Trailing 12-Months
Company Description
Bolt Biotherapeutics
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
---
BOLT Stock 12 Months Forecast
Average Price Target
$6.50
▲(460.59% Upside)
Technical Analysis
Best Analysts Covering BOLT
1 Year
1 Year Success Rate
4/13 ratings generated profit
1 Year Average Return
-33.21%
reiterated a buy rating last month
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -33.21% per trade.
---